Patrick Pace - Encision Executive Chairman of the Board
ECIADelisted Stock | USD 0.46 0.00 0.00% |
Chairman
Dr. Patrick W. Pace, M.D., is an Independent Executive Chairman of the Board of Encision Inc., effective September 3, 2013. Dr. Pace is an Advisor to EDG Partners, a healthcare focused private equity firm. Dr. Pace background includes over 10 years of financial experience in the healthcare sector. From 2009 to 2011, he was a Managing Director at Citadel Securities, where he was part of the inaugural team that helped launch the firm investment banking and credit sales and trading efforts. In this capacity, he provided credit analysis for the healthcare sector. From 2006 to 2009, he was a Vice President at AIG Investments, where he focused on healthcare investments in the high yield bond market. From 2001 to 2006, Dr. Pace held various positions at UBS, including serving as Senior Analyst in equity research covering the medical device sector from 2003 to 2006. Dr. Pace also serves as Chairman of the board of directors for Nanospectra Biosciences, Inc., a privately held medical device company since 2013.
Age | 42 |
Tenure | 11 years |
Phone | 303 444 2600 |
Web | https://www.encision.com |
Encision Management Efficiency
The company has return on total asset (ROA) of (0.0831) % which means that it has lost $0.0831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Encision's management efficiency ratios could be used to measure how well Encision manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 206 K in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Encision has a current ratio of 3.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Encision until it has trouble settling it off, either with new capital or with free cash flow. So, Encision's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Encision sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Encision to invest in growth at high rates of return. When we think about Encision's use of debt, we should always consider it together with cash and equity.
Similar Executives
Found 4 records | CHAIRMAN Age | ||
William Mitchell | Environmmtl Tectonic | 69 | |
Joseph Cremonese | Scientific Industries | 81 | |
Regina Anderson | Procyon | 37 | |
Daniel Rooney | SCI Engineered Materials | 63 |
Management Performance
Return On Equity | -0.22 | ||||
Return On Asset | -0.0831 |
Encision Leadership Team
Elected by the shareholders, the Encision's board of directors comprises two types of representatives: Encision inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encision. The board's role is to monitor Encision's management team and ensure that shareholders' interests are well served. Encision's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encision's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brad Greathouse, Vice President - Regulatory Affairs & Quality Assurance | ||
Michael Biggs, VP of Engineering | ||
Peter Geary, Vice President - Operations | ||
Mala Ray, Controller, Treasurer and Corporate Secretary | ||
Gregory Trudel, CEO and President and Director | ||
Valerie Ray, VP of Operations | ||
Brian Jackman, VP Marketing | ||
Robert Fries, Independent Director | ||
Ruediger NaumannEtienne, Independent Director | ||
Patrick Pace, Executive Chairman of the Board | ||
David Newton, Co-Founder, VP of Technology and Director | ||
Vern Kornelsen, Independent Director |
Encision Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Encision a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.22 | ||||
Return On Asset | -0.0831 | ||||
Profit Margin | (0.09) % | ||||
Operating Margin | (0.09) % | ||||
Current Valuation | 6.09 M | ||||
Shares Outstanding | 11.76 M | ||||
Shares Owned By Insiders | 45.79 % | ||||
Shares Owned By Institutions | 8.20 % | ||||
Number Of Shares Shorted | 3.19 K | ||||
Price To Earning | 16.67 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Encision in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Encision's short interest history, or implied volatility extrapolated from Encision options trading.
Pair Trading with Encision
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Encision position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encision will appreciate offsetting losses from the drop in the long position's value.Moving against Encision Pink Sheet
0.57 | RVP | Retractable Technologies | PairCorr |
0.47 | INFU | InfuSystems Holdings | PairCorr |
The ability to find closely correlated positions to Encision could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Encision when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Encision - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Encision to buy it.
The correlation of Encision is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Encision moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Encision moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Encision can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Encision Pink Sheet
If you are still planning to invest in Encision check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Encision's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stocks Directory Find actively traded stocks across global markets |